Is nasal cannula oxygen removal necessary during cardioversion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nasal Cannula Oxygen During Cardioversion: No Removal Required

You do not need to remove nasal cannula oxygen when performing cardioversion. Standard low-flow nasal cannula (≤5 L/min) can safely remain in place during the procedure, as it does not generate significant aerosols or create a fire hazard at typical flow rates used in clinical practice.

Rationale for Leaving Nasal Cannula in Place

Oxygen Delivery Characteristics

  • Low-flow nasal cannula (1-6 L/min) does not create an occlusive seal and delivers oxygen concentrations of approximately 24-50% FiO2, which is well below the threshold for combustion risk during brief electrical procedures 1.
  • The British Thoracic Society guidelines emphasize that nasal cannula is preferred for medium-concentration oxygen therapy due to patient comfort and the ability to maintain oxygenation during procedures without interference 1, 2.

Safety Considerations

  • Cardioversion is a brief procedure (lasting seconds), and maintaining continuous oxygenation is more important than theoretical fire risk at low flow rates 3.
  • Unlike high-flow nasal cannula (30-70 L/min), standard nasal cannula at ≤5 L/min does not generate significant aerosols and poses minimal infection control concerns 4.
  • The guidelines for airway management recommend that low-flow nasal oxygen may provide oxygenation during apnea and can delay hypoxemia, with no evidence suggesting it generates problematic aerosols 4.

Clinical Algorithm for Oxygen Management During Cardioversion

Standard Approach (Most Patients)

  • Keep nasal cannula in place at current flow rate (typically 2-6 L/min) throughout the cardioversion procedure 1.
  • Ensure adequate preoxygenation before sedation if the patient will undergo procedural sedation 3.
  • Monitor oxygen saturation continuously with pulse oximetry 2.

High-Flow Nasal Cannula Considerations

  • If the patient is on high-flow nasal cannula (HFNC) at 30-60 L/min, consider temporarily reducing flow to standard rates (5-6 L/min) during the actual shock delivery, then immediately resume HFNC afterward 5, 6.
  • This precaution is based on the higher oxygen concentrations and flow rates with HFNC, though evidence of fire risk remains theoretical 7.

Face Mask Oxygen

  • If the patient is receiving oxygen via face mask (simple mask or reservoir mask), temporarily remove the mask just before shock delivery and replace immediately afterward 2.
  • Face masks create higher local oxygen concentrations near the chest wall compared to nasal cannula 2.

Important Caveats and Pitfalls

Fire Safety

  • The primary fire risk during cardioversion comes from high oxygen concentrations near ignition sources, but standard nasal cannula at typical flow rates does not create this risk 4.
  • Ensure the nasal cannula tubing is not in direct contact with the defibrillator pads 3.

Oxygenation Priorities

  • Maintaining adequate oxygenation is more critical than removing oxygen delivery devices for brief procedures like cardioversion 3, 1.
  • Patients requiring supplemental oxygen are already at risk for hypoxemia, and interrupting oxygen delivery—even briefly—can lead to rapid desaturation 8.

Non-Invasive Ventilation

  • If the patient is on NIV (CPAP or BiPAP), you must disconnect the device before cardioversion due to the occlusive mask interface and higher pressures 9.
  • Have a plan to rapidly resume NIV or escalate to intubation if the patient deteriorates after cardioversion 3.

Related Questions

Can a patient with a gunshot wound to the chest and a chest tube in place, experiencing desaturation, be managed with high flow nasal cannula (HFNC) for oxygenation and ventilation?
Does high-flow oxygen therapy cause vasodilation?
Why use 2 liters of oxygen (O2) and 3 liters of nitrous oxide (N2O) after induction and intubation, instead of 1 liter of oxygen (O2) and 1 liter of nitrous oxide (N2O)?
How often should the nasal cannula be replaced for adults with chronic respiratory conditions, such as Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibrosis, who are on home oxygen therapy?
In a 76‑year‑old woman with approximately 50 % of normal lung capacity receiving pulsed oxygen at 800 mL per minute via nasal cannula from an oxygen concentrator, how long after removing the cannula while seated at rest should we wait for her arterial oxygen saturation to reach a steady‑state value suitable for room‑air testing?
Are there any interactions between Rizatriptan and the patient's current medications, including Fluoxetine, Fremanezumab, Semaglutide, Metformin, Ondansetron, and Levothyroxine?
Are there concerns with using buspirone with Aricept (donepezil) and Namenda (memantine) in patients with Alzheimer's disease?
Can coronary calcium scores decrease with medical therapy?
What is the management for a patient with severe renal impairment, indicated by a Blood Urea Nitrogen (BUN) level of 224 and creatinine level of 21?
What is the calcium level threshold for admitting a patient with hypocalcemia after a post-operative thyroidectomy?
What is the mechanism of action (MOA) and uses of doxylamine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.